Ngā hua rapu - Francesca Aweeka
- E whakaatu ana i te 1 - 20 hua o te 33
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
Model-Based Estimates of the Effects of Efavirenz on Bedaquiline Pharmacokinetics and Suggested Dose Adjustments for Patients Coinfected with HIV and Tuberculosis mā Elin M. Svensson, Francesca Aweeka, Jeong-Gun Park, Florence Marzan, Kelly E. Dooley, Mats O. Karlsson
I whakaputaina 2013Artigo -
4
-
5
Concomitant Efavirenz Reduces Pharmacokinetic Exposure to the Antimalarial Drug Artemether–Lumefantrine in Healthy Volunteers mā Liusheng Huang, Sunil Parikh, Philip J. Rosenthal, Patricia Lizak, Florence Marzan, Grant Dorsey, Diane V. Havlir, Francesca Aweeka
I whakaputaina 2012Artigo -
6
Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: A randomized, placebo-controlled study mā Mustafa A. Noor, Tara Seneviratne, Francesca Aweeka, Joan C. Lo, Jean‐Marc Schwarz, Kathleen Mulligan, Morris Schambelan, Carl Grünfeld
I whakaputaina 2002Artigo -
7
-
8
Contraceptive Efficacy of Oral and Transdermal Hormones When Co-Administered With Protease Inhibitors in HIV-1-Infected Women: Pharmacokinetic Results of ACTG Trial A5188 mā Mary Vogler, Kristine B. Patterson, Lori Kamemoto, Jeong-Gun Park, Heather Watts, Francesca Aweeka, Karin L. Klingman, Susan E. Cohn
I whakaputaina 2010Artigo -
9
Hepatotoxicity Due to a Drug Interaction between Amodiaquine plus Artesunate and Efavirenz mā Polina German, Bryan Greenhouse, Carrie Coates, Grant Dorsey, Philip J. Rosenthal, Edwin D. Charlebois, Niklas Lindegårdh, Diane V. Havlir, Francesca Aweeka
I whakaputaina 2007Carta -
10
Failure to Detect Nelfinavir in the Cerebrospinal Fluid of HIV-1-Infected Patients With and Without AIDS Dementia Complex mā Francesca Aweeka, Anura L. Jayewardene, Silvija I. Staprans, S. Eralp Bellibas, Brian P. Kearney, Patricia Lizak, Tatjana Novakovic-Agopian, Richard W. Price
I whakaputaina 1999Artigo -
11
Interruption of Treatment with Individual Therapeutic Drug Classes in Adults with Multidrug‐Resistant HIV‐1 Infection mā Steven G. Deeks, Rebecca Hoh, Torsten B. Neilands, Teri Liegler, Francesca Aweeka, Christos J. Petropoulos, Robert M. Grant, Jeffrey N. Martin
I whakaputaina 2005Artigo -
12
Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing mā Maria Garcia‐Cremades, Belén P. Solans, Emma Hughes, Jacqueline P. Ernest, Erika Wallender, Francesca Aweeka, Anne F. Luetkemeyer, Radojka M. Savić
I whakaputaina 2020Artigo -
13
-
14
CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children mā Akihiko Saitoh, Elizabeth Sarles, Edmund V. Capparelli, Francesca Aweeka, Andrea Kovács, Sandra Burchett, Andrew Wiznia, Sharon Nachman, Terence Fenton, Stephen A. Spector
I whakaputaina 2007Artigo -
15
Lopinavir/Ritonavir Affects Pharmacokinetic Exposure of Artemether/Lumefantrine in HIV-Uninfected Healthy Volunteers mā Polina German, Sunil Parikh, Jody Lawrence, Grant Dorsey, Philip J. Rosenthal, Diane V. Havlir, Edwin D. Charlebois, Warunee Hanpithakpong, Niklas Lindegårdh, Francesca Aweeka
I whakaputaina 2009Artigo -
16
Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection mā Silvija I. Staprans, Natalia Marlowe, David V. Glidden, Tatjana Novakovic-Agopian, Robert M. Grant, Melvyn P. Heyes, Francesca Aweeka, Steven G. Deeks, Richard W. Price
I whakaputaina 1999Artigo -
17
Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047 mā Carl J. Fichtenbaum, John G. Gerber, Susan L. Rosenkranz, Yoninah Segal, Judith A. Aberg, Terrence F. Blaschke, Beverly Alston, Fang Fang, Bradley W. Kosel, Francesca Aweeka
I whakaputaina 2002Artigo -
18
High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL-17 against M. tuberculosis antigen mā Paul Ogongo, Anthony Tran, Florence Marzan, David Gingrich, Melissa Krone, Francesca Aweeka, Cecilia S. Lindestam Arlehamn, Jeffrey N. Martin, Steven G. Deeks, Peter W. Hunt, J. Ernst
I whakaputaina 2024Artigo -
19
Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221... mā Anne F. Luetkemeyer, Susan L. Rosenkranz, Darlene Lu, Florence Marzan, Prudence Ive, Evelyn Hogg, Susan Swindells, Constance A. Benson, Beatriz Grinsztejn, Ian Sanne, Diane V. Havlir, Francesca Aweeka
I whakaputaina 2013Artigo -
20
Antiretroviral Agents and Prevention of Malaria in HIV-Infected Ugandan Children mā Jane Achan, Abel Kakuru, Gloria Ikilezi, Theodore Ruel, Tamara D. Clark, Christian Nsanzabana, Edwin D. Charlebois, Francesca Aweeka, Grant Dorsey, Philip J. Rosenthal, Diane V. Havlir, Moses R. Kamya
I whakaputaina 2012Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Immunology
Viral load
Antiretroviral therapy
Human immunodeficiency virus (HIV)
Pharmacology
Pharmacokinetics
Virology
Biology
Ritonavir
Efavirenz
Malaria
Plasmodium falciparum
Artemisinin
Genetics
Lopinavir
Lopinavir/ritonavir
Artemether
Artemether/lumefantrine
Biochemistry
Cmax
Lumefantrine
Pathology
Chemistry
Dosing
Drug
Endocrinology
Gastroenterology
Metabolism